Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-01-18Clinical Trial Update: Adjuvant Targeted-therapy for Patients With Resected High-risk EGFR-mutant Stage IB-IIA Non-small Cell Lung Carcinoma [Phase 2]
Phase 2 clinical trial update evaluating adjuvant targeted therapy for patients with resected high-risk EGFR-mutant stage IB-IIA non-small c…
-
CLINICAL_TRIALS trial_result · 2022-01-14Clinical Trial Update: Tislelizumab as Cross-line Treatment for Advanced NSCLC [Phase 2]
Phase 2 clinical trial evaluating tislelizumab as a cross-line treatment for advanced non-small-cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2022-01-12Clinical Trial Update: BATTLE-2 Program: A Biomarker-Integrated Targeted Therapy Study in Previously Treated Patients With Advanced Non-Small Cell Lung Cancer [Phase 2]
Phase 2 trial update for the BATTLE-2 program in previously treated advanced non-small cell lung cancer evaluating a biomarker-integrated ta…
-
CLINICAL_TRIALS trial_result · 2022-01-11Clinical Trial Update: A Study Evaluating the Efficacy and the Safety of First-line Chemotherapy Combined With the Therapeutic Vaccine Named TG4010 and Nivolumab in Patients With Advanced Non-squamous Non-Small Cell Lung Cancer (NSCLC) [Phase 2]
Phase 2 study evaluating first-line chemotherapy with TG4010 therapeutic vaccine and nivolumab in advanced non-squamous NSCLC; trial complet…
-
CLINICAL_TRIALS trial_result · 2022-01-11Clinical Trial Update: Study of Epacadostat (INCB024360) Alone and In Combination With Pembrolizumab (MK-3475) With Chemotherapy and Pembrolizumab Without Chemotherapy in Participants With Advanced Solid Tumors (MK-3475-434) [Phase 1]
Phase 1 trial evaluating epacadostat alone and in combination with pembrolizumab, with or without chemotherapy, in participants with advance…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-01-11Clinical Trial Update: DS-1205c With Osimertinib for Metastatic or Unresectable Epidermal Growth Factor Receptor (EGFR)-Mutant Non-Small Cell Lung Cancer [Phase 1]
Phase 1 trial of DS-1205c combined with osimertinib in metastatic or unresectable EGFR-mutant non-small cell lung cancer was terminated; res…
-
CLINICAL_TRIALS trial_result · 2022-01-06Clinical Trial Update: Consolidation Pembrolizumab Following Chemoradiation in Patients With Inoperable/Unresectable Stage III NSCLC [Phase 2]
Phase 2 trial evaluating consolidation pembrolizumab after chemoradiation in patients with inoperable/unresectable stage III non-small cell …
-
CLINICAL_TRIALS trial_result · 2022-01-05Clinical Trial Update: Ensatinib Treat Second-generation ALK-TKI Resistance After Second-generation ALK-TKI Resistance [Phase 2]
Phase 2 clinical trial evaluating ensatinib for patients with ALK-positive non-small cell lung cancer who have developed resistance to a sec…
-
CLINICAL_TRIALS trial_result · 2022-01-04Clinical Trial Update: SHR-1701 for Consolidation Therapy After Concurrent Chemoradiotherapy in Inoperable Stage III NSCLC [Phase 2]
Phase 2 clinical trial update for SHR-1701 as consolidation therapy after chemoradiotherapy in inoperable stage III non-small cell lung canc…
-
CLINICAL_TRIALS trial_result · 2022-01-03Clinical Trial Update: Study of Thymosin α1 to Reduce Acute Pneumonia For Bulky None-small Cell Lung Cancer [Phase 2]
Phase 2 study evaluating Thymosin α1 to reduce acute pneumonia in bulky non-small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2021-12-30Clinical Trial Update: Phase I/II Study of Lenalidomide Plus Pembrolizumab in Patients With Solid Tumors With Expansion in Non-small Cell Lung Cancer [Phase 1, Phase 2]
Phase 1/II trial evaluating lenalidomide plus pembrolizumab in relapsed or refractory solid tumors with expansion to non-small cell lung can…
-
CLINICAL_TRIALS trial_result · 2021-12-29Clinical Trial Update: Opioid Free Anaesthesia-Analgesia Strategy on Surgical Stress and Immunomodulation in Elective VATS-Lobectomy for NSCLC [Phase 4]
Phase 4 trial evaluating an opioid-free anesthesia-analgesia strategy on surgical stress and immunomodulation in elective VATS-lobectomy for…
-
CLINICAL_TRIALS trial_result · 2021-12-28Clinical Trial Update: Clinical Study of Sintilimab Combined With Chemotherapy in Neoadjuvant Treatment of Non-small Cell Lung Cancer [Phase 2]
A Phase 2 clinical trial evaluating sintilimab in combination with chemotherapy as neoadjuvant treatment for non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2021-12-27Clinical Trial Update: To Compare the Efficacy and Safety of BP102 vs. Avastin® in Combination With Paclitaxel/Carboplatin in First-line Treatment of Advanced or Relapsed NSCLC [Phase 3]
Phase 3 trial comparing BP102 versus Avastin in combination with paclitaxel/carboplatin for first-line treatment of advanced or relapsed non…
-
CLINICAL_TRIALS trial_result · 2021-12-23Clinical Trial Update: A Randomized Phase 2 Trial of TAS-114 in Combination With S-1 Versus S-1 [Phase 2]
A randomized Phase 2 trial comparing TAS-114 plus S-1 versus S-1 alone in advanced or metastatic non-small cell lung cancer has posted resul…
-
CLINICAL_TRIALS trial_result · 2021-12-22Clinical Trial Update: The Safety and Efficacy of First-line Lazertinib and Locally Ablative Radiotherapy in Patients With Synchronous Oligo-metastatic EGFR-mutant Non-small Cell Lung Cancer [Phase 2]
A Phase 2 trial investigating first-line Lazertinib combined with locally ablative radiotherapy for patients with synchronous oligo-metastat…
-
CLINICAL_TRIALS trial_result · 2021-12-21Clinical Trial Update: Cisplatin-Pemetrexed Compared With Carboplatin-Paclitaxel-Bevacizumab in KRAS Mutated Non-small Cell Lung Cancer [Phase 3]
Phase 3 trial comparing cisplatin-pemetrexed versus carboplatin-paclitaxel-bevacizumab in KRAS-mutated non-small cell lung cancer is ongoing…
-
CLINICAL_TRIALS trial_result · 2021-12-17Clinical Trial Update: Ceritinib in Combination With Stereotactic Ablative Radiation Metastatic Lung Adenocarcinoma [Phase 2]
Phase 2 trial evaluating ceritinib with stereotactic ablative radiation in ALK-positive non-small cell lung cancer was terminated; results p…
-
CLINICAL_TRIALS trial_result · 2021-12-14Clinical Trial Update: Phase 2 Study of Brigatinib in Japanese Participants With Anaplastic Lymphoma Kinase (ALK)-Positive Non-Small Cell Lung Cancer (NSCLC) [Phase 2]
Phase 2 study of brigatinib in Japanese participants with ALK-positive non-small cell lung cancer has completed and results have been posted…
-
CLINICAL_TRIALS trial_result · 2021-12-13Clinical Trial Update: A Dose Escalation Study Of PF-06801591 In Melanoma, Head And Neck Cancer (SCCHN), Ovarian, Sarcoma, Non-Small Cell Lung Cancer, Urothelial Carcinoma or Other Solid Tumors [Phase 1]
A Phase 1 dose-escalation study of PF-06801591 in multiple solid tumors including melanoma, head and neck cancer, ovarian cancer, sarcoma, n…
-
CLINICAL_TRIALS trial_result · 2021-12-08Clinical Trial Update: Pembrolizumab, Lenvatinib and Chemotherapy After TKIs in NSCLC [Phase 2]
Phase 2 trial evaluating pembrolizumab, lenvatinib, and chemotherapy after TKIs in non-small cell lung cancer with EGFR activating mutations…
-
CLINICAL_TRIALS trial_result · 2021-12-02Clinical Trial Update: A Study of MRG002 in the Treatment of Patients With HER2-mutated Unresectable/Metastatic Non-small Cell Lung Cancer (NSCLC). [Phase 2]
Phase 2 clinical trial update for MRG002 in HER2-mutated unresectable/metastatic non-small cell lung cancer (NSCLC).
-
CLINICAL_TRIALS trial_result · 2021-11-30Clinical Trial Update: A Phase II Study of HMPL-504 in Lung Sarcomatoid Carcinoma and Other Non-small Cell Lung Cancer [Phase 2]
Phase II study of HMPL-504 in lung sarcomatoid carcinoma and other non-small cell lung cancers is ongoing with an unknown status.
-
CLINICAL_TRIALS trial_result · 2021-11-24Clinical Trial Update: A Study of SHR-1701 Plus Bevacizumab and Chemotherapy in Non-Small-Cell-Lung-Cancer [Phase 3]
Phase 3 study investigating SHR-1701 with bevacizumab and chemotherapy in advanced or metastatic non-squamous non-small-cell lung cancer; cu…
-
CLINICAL_TRIALS trial_result · 2021-11-24Clinical Trial Update: A Study of LY3499446 in Participants With Advanced Solid Tumors With KRAS G12C Mutation [Phase 1, Phase 2]
Phase 1/2 trial of LY3499446 in advanced solid tumors with KRAS G12C has been terminated; results posted in 2021.